Dr. Niesmann And Dr. Othlinghaus GbR

This site in Bochum, Germany is active in skin and connective tissue disease research, with studies focused on common and chronic conditions such as psoriasis, hidradenitis suppurativa, vitiligo, and actinic keratosis. The trials are designed to assess how well new treatments work and how safe they are for people living with persistent inflammatory or pigment-related skin disorders.

• Testing new therapies for moderate to severe plaque psoriasis and related inflammatory skin conditions
• Evaluating treatment options for hidradenitis suppurativa, a painful chronic skin disease
• Studying approaches for nonsegmental vitiligo to improve skin repigmentation care
• Assessing therapies for palmoplantar pustulosis and other difficult-to-treat dermatologic conditions

Overall, the research at this hospital/clinic site centers on improving symptom control, long-term safety, and treatment effectiveness in chronic dermatologic disease.

A major part of the clinical trial portfolio involves immune system diseases, especially psoriasis in several forms, including moderate to severe plaque psoriasis and palmoplantar pustulosis. These studies are exploring new ways to reduce inflammation, improve skin symptoms, and support longer-term disease control.

• Investigating newer treatments for plaque psoriasis to improve disease management
• Comparing therapies for palmoplantar pustulosis, a challenging inflammatory skin condition
• Examining long-term safety and tolerability in chronic psoriatic disease
• Assessing whether emerging medicines can offer better symptom relief than placebo

These trials reflect a strong focus on advancing dermatology and immunology through better treatment options for patients with ongoing inflammatory skin disease.

The site also participates in trials within hormonal diseases, including studies on female androgenetic alopecia, a form of hormone-related hair loss. This research is aimed at understanding whether new or repurposed treatments can improve hair growth and overall treatment response in women affected by thinning hair.

• Exploring treatment strategies for female androgenetic alopecia
• Evaluating whether therapy can improve hair density and visible regrowth
• Studying the balance of effectiveness and safety in hormone-related hair loss care

At Dr. Niesmann And Dr. Othlinghaus GbR, this area adds a broader perspective beyond inflammatory skin disease by addressing quality-of-life concerns linked to hormonal imbalance.

Another important research direction includes chronic venous ulcers and actinic keratosis. These trials are focused on improving wound closure in long-lasting leg ulcers and on reducing the risk of progression from precancerous skin lesions to more serious disease, while also monitoring safety over time.

• Studying wound healing in chronic venous ulcers
• Evaluating treatments for actinic keratosis on sun-exposed skin
• Assessing whether therapy can help prevent invasive squamous cell carcinoma
• Supporting research on skin recovery and lesion control in older or chronically affected patients

This work combines dermatology and oncology-related prevention, with the goal of improving outcomes for patients at risk of persistent wounds or sun-related skin damage.

The trial portfolio also includes studies in platysma prominence, reflecting interest in skin and soft-tissue conditions beyond inflammatory disease. These investigations are designed to evaluate whether new treatments can improve appearance-related concerns while maintaining acceptable safety and tolerability.

• Assessing treatment options for moderate to severe platysma prominence
• Studying whether therapy can improve visible neck-line concerns
• Monitoring safety and patient response in a non-inflammatory skin-related condition

This adds a specialized aesthetic medicine component to the research profile at the site, alongside its stronger focus on chronic dermatologic diseases.